hrvatski jezikClear Cookie - decide language by browser settings

(COST Action EUROGRAFT) Crossland, Rachel E.; Perutelli, Francesca; Bogunia- Kubik, Katarzyna; Mooney, Nuala; Milutin Gašperov, Nina; Pučić-Baković, Maja; Greinix, Hildegard; Weber, Daniela; Holler, Ernst; Pulanić, Dražen; Wolff, Daniel; Dickinson, Anne M.; Inngjerdingen, Marit; Grce, Magdalena (2020) . Frontiers in Immunology, 11 . pp. 602547-16. ISSN 1664-3224

PDF - Published Version - article
Available under License Creative Commons Attribution.

Download (833kB) | Preview


Prognostic, diagnostic or predictive biomarkers are urgently needed for assessment of chronic graft-versus-host disease (cGvHD), a major risk for patients undergoing allogeneic hematopoietic stem cell transplantation. The main goal of this review generated within the COST Action EUROGRAFT “Integrated European Network on Chronic Graft Versus Host Disease” was to identify potential novel biomarkers for cGvHD besides the widely accepted molecular and cellular biomarkers. Thus, the focus was on cellular biomarkers, alloantibodies, glycomics, endothelial derived particles, extracellular vesicles, microbiome, epigenetic and neurologic changes in cGvHD patients. Both host-reactive antibodies in general, and particularly alloantibodies have been associated with cGvHD and require further consideration. Glycans attached to IgG modulate its activity and represent a promising predictive and/or stratification biomarker for cGVHD. Furthermore, epigenetic changes such as microRNAs and DNA methylation represent potential biomarkers for monitoring cGvHD patients and novel targets for developing new treatment approaches. Finally, the microbiome likely affects the pathophysiology of cGvHD ; bacterial strains as well as microbial metabolites could display potential biomarkers for dysbiosis and risk for the development of cGvHD. In summary, although there are no validated biomarkers currently available for clinical use to better inform on the diagnosis, prognosis or prediction of outcome for cGvHD, many novel sources of potential markers have shown promise and warrant further investigation using well characterized, multi-center patient cohorts.

Item Type: Article
Uncontrolled Keywords: chronic graft-versus-host disease (cGvHD) ; alloantibodies ; glycomics ; endothelial derived particles, extracellular vesicles ; epigenetic changes ; microbiome ; cellular biomarkers
Subjects: BIOMEDICINE AND HEALTHCARE > Basic Medical Sciences
BIOMEDICINE AND HEALTHCARE > Clinical Medical Sciences
Divisions: Division of Molecular Medicine
Project titleProject leaderProject codeProject type
Novi biomarkeri kronične bolesti presatka protiv primatelja-Bio-cGVHDDražen PulanićIP-2016-06-8046HRZZ
Depositing User: Magdalena Grce
Date Deposited: 17 Nov 2021 13:17
DOI: 10.3389/fimmu.2020.602547

Actions (login required)

View Item View Item


Downloads per month over past year

Increase Font
Decrease Font
Dyslexic Font